五芳斋(603237) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥454,769,119.01, representing a decrease of 14.45% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥13,958,315.43, with a year-to-date net profit of ¥228,415,989.46, down 19.23% year-on-year[5] - The basic and diluted earnings per share for the quarter were both -¥0.1663, a decrease of 22.12% compared to the previous year[6] - Total operating revenue for the first three quarters of 2022 was CNY 2,263,587,714.95, a decrease of 15.1% compared to CNY 2,667,531,360.51 in the same period of 2021[20] - Net profit for Q3 2022 was CNY 228,666,861.10, a decline of 19.3% from CNY 283,276,468.09 in Q3 2021[22] - Basic and diluted earnings per share for Q3 2022 were CNY 2.9151, down from CNY 3.7431 in Q3 2021[23] - The company reported a total comprehensive income of CNY 228,540,848.78 for Q3 2022, down from CNY 283,347,098.35 in Q3 2021[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,791,612,969.87, an increase of 61.25% from the end of the previous year[6] - Total current assets as of September 30, 2022, amount to ¥1,823,801,078.96, a significant increase from ¥703,340,753.42 at the end of 2021[16] - Total assets as of September 30, 2022, are ¥2,791,612,969.87, compared to ¥1,731,183,130.90 at the end of 2021[17] - Total liabilities increased to ¥661,451,964.57 from ¥609,003,965.65, reflecting a growth of approximately 8%[17] - Total liabilities as of Q3 2022 amounted to CNY 949,988,977.39, an increase of 7.9% from CNY 880,038,565.87 in the previous year[21] - Non-current liabilities include long-term borrowings of ¥140,749,500.00, up from ¥92,260,400.66[17] Cash Flow - The cash flow from operating activities for the year-to-date was ¥388,673,116.80, reflecting a decrease of 10.28% compared to the previous year[6] - Cash inflow from operating activities for the first three quarters of 2022 was CNY 2,418,663,796.61, compared to CNY 2,754,586,543.94 in the same period of 2021, reflecting a decrease of 12.2%[24] - The net cash flow from operating activities for Q3 2022 was approximately $388.67 million, a decrease from $433.20 million in Q3 2021, representing a decline of about 10.5%[25] - The total cash inflow from investing activities was approximately $262.01 million, down from $904.88 million in the previous year, indicating a decrease of about 71%[25] - The net cash flow from investing activities was negative at approximately -$138.53 million, compared to -$107.94 million in Q3 2021, reflecting a worsening of about 28.4%[25] - The cash inflow from financing activities totaled approximately $988.18 million, significantly higher than $152.13 million in Q3 2021, marking an increase of about 549%[25] - The net cash flow from financing activities was approximately $781.95 million, a substantial improvement from -$291.93 million in the same quarter last year[25] - The total cash and cash equivalents at the end of Q3 2022 amounted to approximately $1.29 billion, compared to $443.38 million at the end of Q3 2021, showing an increase of about 190%[25] Shareholder Information - Shareholders' equity attributable to the company was ¥1,839,246,692.48, up 116.57% year-on-year due to the issuance of new shares[6] - Total number of common shareholders at the end of the reporting period is 18,579[13] - The largest shareholder, Wufangzhai Group, holds 30,493,283 shares, representing 30.27% of total shares[13] Inventory and Receivables - The company reported a significant increase in inventory, with current inventory at ¥224,473,565.16 compared to ¥315,112,154.99 previously[16] - Accounts receivable rose to ¥221,073,391.25 from ¥42,377,021.75, indicating a growth of over 420%[16] Research and Development - Research and development expenses for Q3 2022 were CNY 14,120,284.45, an increase of 77.5% from CNY 7,978,322.27 in Q3 2021[21] Future Outlook - The company plans to enhance operational efficiency and reduce costs to improve future profitability[11] - The company has not disclosed any new product developments or market expansion strategies in the current report[15]